Thymosin Alpha-1 10mg
$85.00
Thymosin Alpha-1 (TA1) is a synthetic 28-amino-acid peptide investigated in preclinical cellular defense, cytokine modulation, and T-cell differentiation models. Supplied as a stable 10mg lyophilized vial. Third-party HPLC-verified >99% purity. For research use only.
In stock
Free shipping on orders over $149!
- 99% Purity (HPLC-MS Verified)
- Independent Third-Party Tested
- USA GMP Manufactured
- Complimentary BAC Water
- Ships in 24 Hours (USA)
Disclaimer: This product is intended solely for laboratory research purposes. It is not for human consumption, medical use, veterinary use, or household application. All product information on this website is provided for educational purposes only. Researchers must handle this product with appropriate safety protocols and comply with all applicable regulations. Please review our Terms & Conditions before purchasing.
Thymosin Alpha-1 (TA1) 10mg Peptide
Thymosin Alpha-1 (TA1) is a highly purified synthetic 28-amino-acid peptide engineered to mimic a naturally occurring sequence originally isolated from thymic tissue. In modern laboratory settings, TA1 serves as a premier investigational tool for studying in vitro immune modulation, cytokine expression profiling, and Toll-Like Receptor (TLR) signaling.
For investigators looking to buy thymosin alpha 1 for their preclinical models, Protide Health supplies this compound as a stable, lyophilized powder. By providing a reliable exogenous source of this peptide, we enable researchers to map complex cellular defense mechanisms in a controlled, standardized environment.
Peptide Type: Synthetic Immunomodulatory Peptide Sequence
Vial Content: 10mg Thymosin Alpha-1 (TA1)
Form: Lyophilized (Freeze-Dried) for maximum biochemical stability
Mechanism of Action: Cellular Defense and Cytokine Modulation
Thymosin Alpha-1 is synthesized to investigate the core pathways of cellular immunity and dendritic cell activation. Its primary mechanism of action in preclinical models involves the regulation of inflammatory responses and the maturation of specific cellular subsets.
T-Cell Maturation Models: TA1 is frequently utilized in cell cultures to observe the differentiation and maturation of T-lymphocytes (such as CD4+ and CD8+ subsets), allowing researchers to track adaptive immune signaling.
Cytokine Expression Profiling: In in vitro assays, TA1 is observed to increase the production of IL-2, IFN-γ, and IL-12 while simultaneously downregulating pro-inflammatory markers (like IL-6 and TNF-α). Researchers use this dynamic to study Th1/Th2 response balancing.
Toll-Like Receptor (TLR) Interaction: TA1 interacts directly with TLR2 and TLR9 pathways in laboratory models, providing a framework to study innate immune responses to microbial and viral proxies.
Advanced Research Applications for Thymosin Alpha-1
1. Innate Immunity & NK Cell Assays
Thymosin Alpha-1 is a primary compound for investigating innate cellular defense. Laboratory research focuses on how TA1 upregulates Natural Killer (NK) cell activity and enhances MHC class I and II expression on dendritic cells, tracking how these mechanisms improve antigen presentation in isolated tissue cultures.
2. Inflammatory Modulation Studies
Researchers utilize TA1 to investigate the biochemistry of chronic tissue stress. By studying its interaction with NF-κB pathways and the promotion of IL-10, investigators map how TA1 reduces markers of excessive inflammation and protects cellular integrity during modeled immune overactivation.
3. Preclinical Antiviral & Cellular Surveillance Models
Because of its distinct ability to stimulate immune markers without causing overstimulation, TA1 is heavily researched in viral surrogate models. Animal and cellular assays utilize TA1 to observe the upregulation of cytotoxic responses and cellular surveillance mechanisms.
Specifications Table: Thymosin Alpha-1
| Parameter | Technical Details |
|---|---|
| Product Name | Thymosin Alpha-1 (TA1) |
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn |
| Vial Weight | 10mg (Active Peptide) |
| Molecular Weight | ~3108.3 g/mol |
| Purity Grade | 99%+ (Verified via HPLC/MS) |
| Solubility | Reconstitute with Bacteriostatic Water |
| Intended Use | Laboratory Research Only |
Where is the best place to find Thymosin Alpha-1 for sale?
Qualified researchers looking for highly purified thymosin alpha-1 for sale can acquire it directly through Protide Health. We provide research-grade thymosin alpha 1 10mg vials explicitly manufactured for in vitro and animal modeling.
Is there a Thymosin Alpha-1 COA available?
Yes. Trust and purity are paramount in laboratory settings. Every batch of TA1 undergoes strict third-party testing, and a current thymosin alpha-1 COA (Certificate of Analysis) is available to verify its >99% purity and accurate molecular weight.
What is the Thymosin Alpha 1 price and injection cost?
When budgeting for laboratory supplies, researchers sometimes search for the thymosin alpha 1 injection cost based on clinical proxies. However, Protide Health supplies TA1 strictly as a lyophilized powder for laboratory reconstitution, not for human injection. The thymosin alpha-1 price reflects the high-yield 10mg vial size, which provides ample compound for extended in vitro assays or multi-phase animal studies at a competitive, transparent cost.
Why do laboratories buy Thymosin Alpha 1 peptide in 10mg vials?
Unlike smaller 2mg or 5mg variants that require frequent reordering, the thymosin alpha 1 10mg format allows researchers to run comprehensive, dose-dependent assays (such as mapping prolonged cytokine expression) using a single, uniform batch.
Conclusion: Summary for Researchers
Thymosin Alpha-1 (TA1) represents a highly targeted research tool for exploring complex immune modulation and cellular defense networks. By promoting T-cell maturation, upregulating NK cell activity, and balancing cytokine production, it provides a multifaceted platform for investigating innate and adaptive immune signaling. Available exclusively for laboratory use in a high-yield 10mg variant, this peptide is a vital asset for advancing preclinical immunology discovery.
Citations
Goldstein AL et al., 1977. Isolation and characterization of Thymosin Alpha-1. Proceedings of the National Academy of Sciences.
Sztein MB et al., 1986. Modulation of T-cell function and interleukin-2 production by Thymosin Alpha-1. Journal of Immunology.
Matteucci C et al., 2017. Thymosin alpha 1 and immune modulation in preclinical models. Expert Opinion on Biological Therapy.
Legal Disclaimer
Thymosin Alpha-1 is intended for laboratory research purposes only. It is not approved by the U.S. Food and Drug Administration (FDA) or any regulatory authority for human consumption, medical use, or therapeutic application. It is intended solely for investigational use in controlled laboratory settings by qualified researchers. Protide Health does not endorse or promote the use of Thymosin Alpha-1 in humans or animals outside of approved research protocols. Researchers must comply with all applicable local, state, and federal regulations, including obtaining necessary approvals for experimental use.








